NCT02293993 2021-03-05Phase 1 Study of SGI-110 in Patients With Acute Myeloid LeukemiaOtsuka Pharmaceutical Co., Ltd.Phase 1 Completed21 enrolled 13 charts
NCT02892318 2020-03-13A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML)Hoffmann-La RochePhase 1 Completed40 enrolled